Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Colorectal Neoplasms

  Free Subscription


1 Ann Oncol
1 Ann Surg
9 Ann Surg Oncol
2 BMC Cancer
3 Cancer
3 Cancer Lett
1 Cancer Res
2 Clin Cancer Res
12 Dis Colon Rectum
1 Eur J Cancer
2 Eur J Surg Oncol
1 Gastrointest Endosc
2 Int J Colorectal Dis
1 J Clin Oncol
2 J Natl Cancer Inst
2 J Pathol
1 Lancet Oncol
1 Oncogene
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Oncol

  1. VAN DER KRUIJSSEN DEW, Elias SG, van de Ven PM, van Rooijen KL, et al
    Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase 3 CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.
    Ann Oncol. 2024 Jun 7:S0923-7534(24)00722-1. doi: 10.1016/j.annonc.2024.
    PubMed         Abstract available

    Ann Surg

  2. BOOTH A, Brinton D, Donahue C, Westfal M, et al
    Extended Pharmacologic Prophylaxis for Venous Thromboembolism after Colon Cancer Surgery is Associated with Improved Long-term Survival: A Natural Experiment in the Chemotherapeutic Benefit of Heparin Derivatives.
    Ann Surg. 2024 Jun 11. doi: 10.1097/SLA.0000000000006376.
    PubMed         Abstract available

    Ann Surg Oncol

  3. JANCZEWSKI LM, Asare EA, Goodman KA
    Updates on the Version 9 American Joint Committee on Cancer Staging System for Anal Cancer.
    Ann Surg Oncol. 2024;31:4155-4158.

  4. SUGUMAR K, Stitzel H, Wu V, Bajor D, et al
    ASO Visual Abstract: Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2024;31:4466-4467.

  5. VAN DER VEN RGFM, van den Heuvel TBM, Rovers KPB, Nienhuijs SW, et al
    ASO Visual Abstract: Towards Equal Access to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy and Survival in Patients with Isolated Colorectal Peritoneal Metastases-A Nationwide Population-Based Study.
    Ann Surg Oncol. 2024;31:4749-4750.

  6. SHAPERA E, Ross S, Pattilachan T, Christodoulou M, et al
    Robotic Biliary Stricturoplasty and Roux-en-Y Hepaticojejunostomy After Hepatic Artery Infusion Pump Injury.
    Ann Surg Oncol. 2024;31:4449-4451.
    PubMed         Abstract available

  7. LAROCHE S, Scatton O, Charlotte F, Bachet JB, et al
    Prognosis of a Heterogeneous TRG Pathological Response to Neoadjuvant Chemotherapy in Patients who Undergo Resection for Colorectal Liver Metastases.
    Ann Surg Oncol. 2024;31:4436-4444.
    PubMed         Abstract available

  8. EL ASMAR A, Kamdem L, Khaled C, Liberale G, et al
    ASO Author Reflections: Histological Growth Patterns of Colorectal Peritoneal Metastases Significantly Affect Prognosis in Patients Presenting for Curative-Intent Cytoreductive Surgery.
    Ann Surg Oncol. 2024;31:4558-4559.

  9. BLANCO ASENSIO N, Aliseda Jover D, Marti-Cruchaga P, Lapuente F, et al
    Anatomical Left Hepatectomy Extended to Caudate Lobe due to Colorectal Metastasis with Intrabiliary Growth: Securing Optimal Margins with a Laennec's Capsule Approach and Vein-Guided Resection.
    Ann Surg Oncol. 2024;31:4447-4448.

  10. SANKARAN R, O'Connor J, Nuliyalu U, Diaz A, et al
    Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
    Ann Surg Oncol. 2024;31:4339-4348.
    PubMed         Abstract available

  11. SUGUMAR K, Stitzel H, Wu V, Bajor D, et al
    Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2024;31:4413-4426.
    PubMed         Abstract available

    BMC Cancer

  12. NIU Y, Wen L, Yang Y, Zhang Y, et al
    Diagnostic performance of Node Reporting and Data System (Node-RADS) for assessing mesorectal lymph node in rectal cancer by CT.
    BMC Cancer. 2024;24:716.
    PubMed         Abstract available

  13. ZHAN ZQ, Huang ZM, Lan QW, Luo YH, et al
    Integrated multi-omics analyses revealed the association between rheumatoid arthritis and colorectal cancer: MYO9A as a shared gene signature and an immune-related therapeutic target.
    BMC Cancer. 2024;24:714.
    PubMed         Abstract available


  14. SUN V, Guthrie KA, Crane TE, Arnold KB, et al
    SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer.
    Cancer. 2024;130:2384-2394.
    PubMed         Abstract available

  15. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.

  16. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.

    Cancer Lett

  17. HUANG C, Tan H, Wang J, Huang L, et al
    beta-hydroxybutyrate restrains colitis-associated tumorigenesis by inhibiting HIF-1alpha-mediated angiogenesis.
    Cancer Lett. 2024;593:216940.
    PubMed         Abstract available

  18. YUAN M, Zhang C, Chen S, Ye S, et al
    PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1.
    Cancer Lett. 2024;597:217007.
    PubMed         Abstract available

  19. CHEN Q, Chen J, Deng Y, Bi X, et al
    Personalized prediction of postoperative complication and survival among Colorectal Liver Metastases Patients Receiving Simultaneous Resection using machine learning approaches: A multi-center study.
    Cancer Lett. 2024;593:216967.
    PubMed         Abstract available

    Cancer Res

  20. LI L, Jiang D, Liu H, Guo C, et al
    Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression.
    Cancer Res. 2024 Jun 11. doi: 10.1158/0008-5472.CAN-23-1878.
    PubMed         Abstract available

    Clin Cancer Res

  21. LENTZ RW, Friedrich TJ, Blatchford PJ, Jordan KR, et al
    A phase II study of potentiation of pembrolizumab with binimetinib and bevacizumab in refractory microsatellite stable colorectal cancer.
    Clin Cancer Res. 2024 Jun 13. doi: 10.1158/1078-0432.CCR-24-0090.
    PubMed         Abstract available

  22. SLATER S, Bryant A, Aresu M, Begum R, et al
    Tissue-free liquid biopsies combining genomic and methylation signals for minimal residual disease detection in patients with early colorectal cancer from the UK TRACC Part B study.
    Clin Cancer Res. 2024 Jun 12. doi: 10.1158/1078-0432.CCR-24-0226.
    PubMed         Abstract available

    Dis Colon Rectum

  23. COLOMBARI R, Perez-Carpio C, Sanchez Rodriguez M, Martinez J, et al
    Preoperative Planning of D3 Right Colectomy With 3-Dimensional Vascular Reconstruction.
    Dis Colon Rectum. 2024;67:e1446-e1447.

  24. ZENG X, Zhang R, Jiang W, Li C, et al
    Local Excision Versus Radical Resection for Grade 2 Rectal Neuroendocrine Tumors: A Multicenter Propensity Score-Matched Analysis.
    Dis Colon Rectum. 2024;67:911-919.
    PubMed         Abstract available

  25. PUNMEECHAO P, Mongkhonsupphawan A, Riansuwan W
    Transanal Excision: Tips and Tricks.
    Dis Colon Rectum. 2024;67:e1455.

  26. KOHRMAN NM, Wlodarczyk JR, Ding L, McAndrew NP, et al
    Rectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy.
    Dis Colon Rectum. 2024;67:920-928.
    PubMed         Abstract available

  27. MIDHA N, Althaf S, Sugoor P
    Fluorescence-Guided Selective Autonomic Nerve-Preserving Robotic Total Mesorectal Excision: Redefining Technology and Techniques.
    Dis Colon Rectum. 2024;67:e1456-e1457.

  28. EVANS C
    Expert Commentary on Kaposi Sarcoma of the Anus: What Does the Colorectal Surgeon Need to Know?
    Dis Colon Rectum. 2024;67:876-877.

  29. PEPONIS T, Perry WRG, Kelley SR
    Ischiorectal Fossa Tumors: 30-year Single-Institution Experience.
    Dis Colon Rectum. 2024;67:896-902.
    PubMed         Abstract available

  30. BOLSHINSKY V, Sweet DE, Vitello DJ, Jia X, et al
    Using CT-Based Pelvimetry and Visceral Obesity Measurements to Predict Total Mesorectal Excision Quality for Patients Undergoing Rectal Cancer Surgery.
    Dis Colon Rectum. 2024;67:929-939.
    PubMed         Abstract available

  31. CAO AMY, Lonne MLR, Moloney JM, Stevenson ARL, et al
    Sutured Transanal Mucosectomy and Plication Procedure.
    Dis Colon Rectum. 2024;67:e1449.

  32. FAIREN ORO C, Favuzza J
    Kaposi Sarcoma of the Anus: What Does the Colorectal Surgeon Need to Know?
    Dis Colon Rectum. 2024;67:873-875.

  33. MCHUGH FT, Ryan EJ, Ryan OK, Tan J, et al
    Management Strategies for Malignant Left-Sided Colonic Obstruction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials and Propensity Score Matching Studies.
    Dis Colon Rectum. 2024;67:878-894.
    PubMed         Abstract available

  34. LEE GC
    Management Strategies for Malignant Left-Sided Colonic Obstruction: A Systematic Review and Network Meta-analysis of Randomized Control Trials and Propensity Score-Matching Studies.
    Dis Colon Rectum. 2024;67:895.

    Eur J Cancer

  35. SWARTJES H, Sijtsma FPC, Elferink MAG, van Erning FN, et al
    Corrigendum to "Trends in incidence, treatment, and relative survival of colorectal cancer in the Netherlands between 2000 and 2021'' Volume 205, July 2024, 114104.
    Eur J Cancer. 2024 Jun 11:114155. doi: 10.1016/j.ejca.2024.114155.

    Eur J Surg Oncol

  36. GAO Z, Qi X, Wang R, Wen Z, et al
    Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108474.
    PubMed         Abstract available

  37. GUO Z, Zhang Z
    Reply to "Improving machine learning predictions for metastases in colorectal cancer".
    Eur J Surg Oncol. 2024 May 24:108441. doi: 10.1016/j.ejso.2024.108441.

    Gastrointest Endosc

  38. BAILE-MAXIA S, Mangas-Sanjuan C, Ladabaum U, Ardila CS, et al
    Gastrointest Endosc. 2024 Jun 6:S0016-5107(24)03257.
    PubMed         Abstract available

    Int J Colorectal Dis

  39. CARVALHO A, Limbert M, Cabral F, Fareleira A, et al
    The impact of methylene blue in colon cancer: a retrospective multicentric study.
    Int J Colorectal Dis. 2024;39:90.
    PubMed         Abstract available

  40. OUCHI K, Takahashi S, Sasaki K, Yoshida Y, et al
    Genome-wide DNA methylation status is a predictor of the efficacy of anti-EGFR antibodies in the second-line treatment of metastatic colorectal cancer: Translational research of the EPIC trial.
    Int J Colorectal Dis. 2024;39:89.
    PubMed         Abstract available

    J Clin Oncol

  41. ANTONIOTTI C, Rossini D, Pietrantonio F, Salvatore L, et al
    Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study.
    J Clin Oncol. 2024 Jun 12:JCO2302728. doi: 10.1200/JCO.23.02728.
    PubMed         Abstract available

    J Natl Cancer Inst

  42. SONG Y, Loomans-Kropp H, Baugher RN, Somerville B, et al
    Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome.
    J Natl Cancer Inst. 2024;116:957-965.
    PubMed         Abstract available

  43. YATES J, Schaufelberger H, Steinacher R, Schar P, et al
    DNA-methylation variability in normal mucosa: a field cancerization marker in patients with adenomatous polyps.
    J Natl Cancer Inst. 2024;116:974-982.
    PubMed         Abstract available

    J Pathol

  44. GEURTS BS, Zeverijn LJ, van Berge Henegouwen JM, van der Wijngaart H, et al
    Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy.
    J Pathol. 2024;263:288-299.
    PubMed         Abstract available

  45. PASTOR-MORATE D, Amigo-Moran L, Garranzo-Asensio M, Rejas-Gonzalez R, et al
    DeltaNp73 and its effector targets promote colorectal peritoneal carcinosis and predict survival.
    J Pathol. 2024;263:328-337.
    PubMed         Abstract available

    Lancet Oncol

  46. YU JH, Xiao BY, Li DD, Jiang W, et al
    Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study.
    Lancet Oncol. 2024 Jun 6:S1470-2045(24)00203.
    PubMed         Abstract available


  47. FENG M, Chai C, Hao X, Lai X, et al
    Inherited KDM6A(A649T) facilitates tumor-immune escape and exacerbates colorectal signet-ring cell carcinoma outcomes.
    Oncogene. 2024;43:1757-1768.
    PubMed         Abstract available

    PLoS One

  48. SEUFFERLEIN T, Lausser L, Stein A, Arnold D, et al
    Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial.
    PLoS One. 2024;19:e0304324.
    PubMed         Abstract available

  49. PROMSUT K, Sangtanoo P, Srimongkol P, Saisavoey T, et al
    A novel peptide derived from Zingiber cassumunar rhizomes exhibits anticancer activity against the colon adenocarcinoma cells (Caco-2) via the induction of intrinsic apoptosis signaling.
    PLoS One. 2024;19:e0304701.
    PubMed         Abstract available

  50. DARWISH MK, Allayeh AK, Ahmed AE, Abdelmaksoud MDE, et al
    Case-control study: Unveiling human polyomaviruses and papillomavirus in Egyptian colorectal cancer patients.
    PLoS One. 2024;19:e0304147.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.